| Drug Name |
Methyl aminolevulinate hydrochloride |
| Drug ID |
BADD_D01424 |
| Description |
Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy. |
| Indications and Usage |
For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette). |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB00992
|
| KEGG ID |
D04988
|
| MeSH ID |
C475457
|
| PubChem ID |
157921
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
46016-7940 |
| UNII |
7S73606O1A
|
| Synonyms |
methyl 5-aminolevulinate | MAOP cpd | methyl aminolaevulinate | Metvix |
